(firstQuint)Lexapro's Efficacy After Dose Escalation in Remission Study.

 In this study, the investigators are going to examine the efficacy of escitalopram after dose escalation and evaluate remission rate.

 This study design is the double-blinded 6-week prospective study.

 It would be useful for clinicians because there were few study of high-dose antidepressant treatment in lack of remission in major depressive disorder patients.

 To control of bias, the investigators included patients with lack of remission after 4-week escitalopram treatment.

.

 Lexapro's Efficacy After Dose Escalation in Remission Study@highlight

The purpose of this study is the evaluation of remission rate between escitalopram 20 mg and 30 mg in patients with major depressive disorder.

